Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease

Early identification of Alzheimer’s disease (AD) risk factors would aid development of interventions to delay the onset of dementia, but current biomarkers are invasive and/or costly to assess. Validated plasma biomarkers would circumvent these challenges. We previously identified the kinase DYRK1A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Psychiatry
Main Authors: Janel, N, Alexopoulos, P, Badel, A, Lamari, F, Camproux, A C, Lagarde, J, Simon, S, Feraudet-Tarisse, C, Lamourette, P, Arbones, M, Paul, J L, Dubois, B, Potier, M C, Sarazin, M, Delabar, J M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5537644/
https://ncbi.nlm.nih.gov/pubmed/28632203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2017.123
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki